nach oben

Erschienen in:

01.01.2023 | News item

Spectrum Laboratory Products recalls 3 lots of discoloured epinephrine

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

The US FDA has published an announcement from Spectrum Laboratory Products of a voluntary recall of three lots of Epinephrine (L-Adrenaline) USP, et al. bulk active pharmaceutical ingredient (API) used to manufacture or compound prescription products. The recall comes after customer complaints of discolouration. …

Spectrum Laboratory Products, Inc. Issues Voluntary Worldwide Recall of Epinephrine (L-Adrenaline) USP Bulk Active Pharmaceutical Ingredient (API) Due to Discoloration of Product Internet Document : 9 Jan 2023. Available from: URL: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/spectrum-laboratory-products-inc-issues-voluntary-worldwide-recall-epinephrine-l-adrenaline-usp-bulk

Titel: Spectrum Laboratory Products recalls 3 lots of discoloured epinephrine
Publikationsdatum: 01.01.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-32269-x

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Spectrum Laboratory Products recalls 3 lots of discoloured epinephrine

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Multiple drugs

Bendamustine/rituximab

Donepezil may cause QT prolongation and torsades de pointes

Gefitinib/nedaplatin/pemetrexed

Meropenem/piperacillin/tazobactam

Metformin